Abstract B37: Small nucleolar RNAs – New players in breast cancer prognosis
Preethi Krishnan(Indiana University School of Medicine), Sambasivarao Damaraju(University of Alberta), John R. Mackey(University of Alberta), Richard Berendt(College of the Holy Cross), Sunita Ghosh(Tata Memorial Hospital), Bo Wang(Henan University Huaihe Hospital and Huaihe Clinical Institute), Dongping Li(University of Lethbridge), Olga Kovalchuk(University of Lethbridge)
Cited by 0
Related Papers
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
|Journal of Clinical Oncology|2009|850
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
|British Journal of Cancer|2008|651
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
|Molecular Cancer Therapeutics|2008|635
A map of human genome variation from population-scale sequencing
|Research at the University of Copenhagen (University of Copenhagen)|2010|550